S

Soleno Therapeutics
D

SLNO

51.350
USD
-1.35
(-2.56%)
مغلق
حجم التداول
40,668
الربح لكل سهم
0
العائد الربحي
-
P/E
-29
حجم السوق
2,758,009,784
أصول ذات صلة الأخبار المقالات
المزيد

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.